ArticleAmerican journal of hypertension2021

Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and COVID-19: Demonstrating the Actionability of Real-World Evidence.

Sean Hennessy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.